Spero Therapeutics, Inc. · NASDAQ:SPRO
GSK plc reported a 16.40% stake in Spero Therapeutics, Inc. (Schedule 13D/A)
Event Mar 27, 2025 · Filed Mar 28, 2025
GSK plc reported a 16.40% stake in Spero Therapeutics, Inc., 9,190,606 shares, with active intent on Mar 27, 2025. Filed Mar 28, 2025 (Schedule 13D/A).
- Stake
- 16.40%
- Shares
- 9,190,606
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GSK PLC | 16.40% | 9,190,606 |